17.01.2014 Views

Ex vivo modeling of HIV persistence in successfully treated subjects ...

Ex vivo modeling of HIV persistence in successfully treated subjects ...

Ex vivo modeling of HIV persistence in successfully treated subjects ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HPDA: Identify<strong>in</strong>g reactivation strategies<br />

Reactivation<br />

(% relative to CD3/CD28)<br />

40<br />

30<br />

20<br />

10<br />

0<br />

n=3<br />

Known anti-latency agents:<br />

PKC activators : prostrat<strong>in</strong>, bryostat<strong>in</strong><br />

HDAC <strong>in</strong>hibitors : SAHA, VPA<br />

The HPDA allows the evaluation <strong>of</strong> the ability <strong>of</strong> anti-latency agents to<br />

reactivate virus <strong>in</strong> latently <strong>in</strong>fected cells from virally suppressed <strong>subjects</strong>.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!